Paradoxical inflammatory switches during biologic therapy: a mechanistic framework, clinical algorithm, and pediatric illustrations

• by Małgorzata Kowacka, Michał Dec, Hubert Arasiewicz

• May 20, 2026

Biologics Commonly Used in Cutaneous Crohn's Disease

Retrospective multicenter cohort highlights genital-predominant presentation patterns and frequent combination therapy use in cutaneous Crohn's disease.

• by Andrea Surnit

• May 27, 2026

• 3 min

Lymphocyte transformation test in pediatric drug hypersensitivity: case series report from a tertiary care hospital

• by Olga Rogozina, Susana Martín-López, Fiorela Cinthia Dueñas López, Zoraida del Solar Moreno, Larry Leiva Castrejon, Daniela Aguilar-Concepción, María Jiménez-González, Ana Martínez Feito, Miguel González-Muñoz, Elena Ramírez

• May 15, 2026

Glutathione peroxidase 2 expression in human tumors: a tissue microarray study on 18,555 tumors

• by Viktoria Chirico, Niklas Jahn, Seyma Büyücek, Nina Schraps, Maximilian Lennartz, Katharina Möller, Elena Bady, Lisa Hornsteiner, Henning Plage, Claudia Hube-Magg, Martina Kluth, Frank Jacobsen, Florian Viehweger, David Dum, Andrea Hinsch, Christoph Fraune, Christian Bernreuther, Patrick Lebok, Guido Sauter, Till S Clauditz, Till Krech, Andreas H Marx, Ronald Simon, Eike Burandt, Natalia Gorbokon, Sarah Minner, Stefan Steurer

• May 4, 2026